Agency Forms Undergoing Paperwork Reduction Act Review, 59982 [E9-27726]
Download as PDF
<![CDATA[
59982
Federal Register / Vol. 74, No. 222 / Thursday, November 19, 2009 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–10–09AI]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an
e-mail to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Evaluation of the Action Plan for the
National Public Health Initiative on
Diabetes and Women’s Health—New—
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Diabetes can have unique and
profound effects on women’s lives and
health. For instance, diabetes is a more
common cause of coronary heart disease
among women than men, and the
prognosis of heart disease is worse for
women with diabetes than men with
diabetes. The burden of diabetes for
women is also unique because the
disease can affect both mothers and
their unborn children. It is projected
that from 2000 to 2025, women will
represent more than half of all cases of
diabetes in the United States.
The National Public Health Initiative
on Diabetes and Women’s Health (‘‘The
Initiative’’) was established to provide
support and resources for the creation
and implementation of a national public
health Action Plan. The Initiative is cosponsored by the American Diabetes
Association (ADA), the American
Association of Diabetes Educators
(AADE), the American Public Health
Association (APHA), the Association of
State and Territorial Health Officials
(ASTHO), and the Centers for Disease
Control and Prevention (CDC).
The Initiative’s Action Plan identifies
gaps in diabetes-related research and
programmatic activities, and strategic
objectives, within the areas of
community health, diabetes state
programs, education and community
outreach, quality of care, research, and
surveillance.
CDC proposes to conduct a survey to
assess collective progress toward
achieving the objectives outlined in the
Action Plan. The survey will also
request information about the specific
strategies, steps, resources and
partnerships that have been employed
to meet the objectives. Respondents will
be the 4 co-sponsors of The Initiative, 20
CDC-funded, state-based diabetes
prevention and control programs
(DPCPs), and approximately 100
private-sector public health
organizations with a focus on diabetes
and/or women’s health. Survey
responses will be compiled into a
progress report and disseminated to
respondents, allowing them to learn
about each other’s activities and the
steps needed to replicate successful
diabetes prevention and control efforts.
Information will be collected once per
year for a period of 3 years, and the
progress report will be updated
annually to reflect recent activities and
progress. Private-sector partners and
state-based partners will submit one
survey response per organization per
year. Co-sponsors will receive a
modified version of the survey. Due to
the size and complexity of the activities
managed by co-sponsors, the cosponsoring organizations will have the
option of submitting multiple survey
responses from different areas of the
organization, in order to capture the full
range of activities conducted. It is
estimated that each co-sponsor will
submit an average of three responses.
Participation in the survey is voluntary.
Information will be collected
electronically through a web-based
survey tool. There are no costs to
respondents other than their time. The
total estimated annualized burden hours
are 66.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
Co-Sponsors ...................................................
State-based DPCPs ........................................
Private Sector Partners ...................................
Co-Sponsor Survey ........................................
Partner Survey ...............................................
Partner Survey ...............................................
Dated: November 10, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E9–27726 Filed 11–18–09; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–D–0533]
erowe on DSK5CLS3C1PROD with NOTICES
BILLING CODE 4163–18–P
Draft Guidance for Industry:
Recommendations for the Assessment
of Blood Donor Suitability, Blood
Product Safety, and Preservation of
the Blood Supply in Response to
Pandemic (H1N1) 2009 Virus;
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
VerDate Nov<24>2008
15:22 Nov 18, 2009
Jkt 220001
PO 00000
Notice.
Frm 00025
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
4
20
100
3
1
1
Avg. burden
per response
(in hrs)
.5
.5
.5
SUMMARY: The Food and Drug
Administration (FDA) is announcing the
availability of a draft document entitled
‘‘Draft Guidance for Industry:
Recommendations for the Assessment of
Blood Donor Suitability, Blood Product
Safety, and Preservation of the Blood
Supply in Response to Pandemic
(H1N1) 2009 Virus’’. This draft guidance
provides recommendations for assessing
blood donor suitability and blood
product safety and maintaining blood
and blood product availability in
response to pandemic (H1N1) 2009
virus. It is intended for establishments
that manufacture Whole Blood and
blood components intended for use in
E:\FR\FM\19NON1.SGM
19NON1
]]>Agencies
[Federal Register Volume 74, Number 222 (Thursday, November 19, 2009)]
[Notices]
[Page 59982]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-27726]
[[Page 59982]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-10-09AI]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-5806.
Written comments should be received within 30 days of this notice.
Proposed Project
Evaluation of the Action Plan for the National Public Health
Initiative on Diabetes and Women's Health--New--National Center for
Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Diabetes can have unique and profound effects on women's lives and
health. For instance, diabetes is a more common cause of coronary heart
disease among women than men, and the prognosis of heart disease is
worse for women with diabetes than men with diabetes. The burden of
diabetes for women is also unique because the disease can affect both
mothers and their unborn children. It is projected that from 2000 to
2025, women will represent more than half of all cases of diabetes in
the United States.
The National Public Health Initiative on Diabetes and Women's
Health (``The Initiative'') was established to provide support and
resources for the creation and implementation of a national public
health Action Plan. The Initiative is co-sponsored by the American
Diabetes Association (ADA), the American Association of Diabetes
Educators (AADE), the American Public Health Association (APHA), the
Association of State and Territorial Health Officials (ASTHO), and the
Centers for Disease Control and Prevention (CDC).
The Initiative's Action Plan identifies gaps in diabetes-related
research and programmatic activities, and strategic objectives, within
the areas of community health, diabetes state programs, education and
community outreach, quality of care, research, and surveillance.
CDC proposes to conduct a survey to assess collective progress
toward achieving the objectives outlined in the Action Plan. The survey
will also request information about the specific strategies, steps,
resources and partnerships that have been employed to meet the
objectives. Respondents will be the 4 co-sponsors of The Initiative, 20
CDC-funded, state-based diabetes prevention and control programs
(DPCPs), and approximately 100 private-sector public health
organizations with a focus on diabetes and/or women's health. Survey
responses will be compiled into a progress report and disseminated to
respondents, allowing them to learn about each other's activities and
the steps needed to replicate successful diabetes prevention and
control efforts.
Information will be collected once per year for a period of 3
years, and the progress report will be updated annually to reflect
recent activities and progress. Private-sector partners and state-based
partners will submit one survey response per organization per year. Co-
sponsors will receive a modified version of the survey. Due to the size
and complexity of the activities managed by co-sponsors, the co-
sponsoring organizations will have the option of submitting multiple
survey responses from different areas of the organization, in order to
capture the full range of activities conducted. It is estimated that
each co-sponsor will submit an average of three responses.
Participation in the survey is voluntary.
Information will be collected electronically through a web-based
survey tool. There are no costs to respondents other than their time.
The total estimated annualized burden hours are 66.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Avg. burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hrs)
----------------------------------------------------------------------------------------------------------------
Co-Sponsors........................... Co-Sponsor Survey....... 4 3 .5
State-based DPCPs..................... Partner Survey.......... 20 1 .5
Private Sector Partners............... Partner Survey.......... 100 1 .5
----------------------------------------------------------------------------------------------------------------
Dated: November 10, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E9-27726 Filed 11-18-09; 8:45 am]
BILLING CODE 4163-18-P
